Deciphering Fc-effector functions against SARS-CoV-2

被引：5

作者：

Beaudoin-Bussieres, Guillaume ^{[1
,2
]}

Finzi, Andres ^{[1
,2
]}

机构：

[1] Ctr Rech CHUM, Montreal, PQ H2X 0A9, Canada

[2] Univ Montreal, Dept Microbiol Infectiol & Immunol, Montreal, PQ H2X 0A9, Canada

来源：

TRENDS IN MICROBIOLOGY | 2024年 / 32卷 / 08期

基金：

加拿大健康研究院;

关键词：

NEUTRALIZING ANTIBODIES; SPIKE; REVEALS; BINDING; PLASMA;

D O I：

10.1016/j.tim.2024.01.005

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Major efforts were deployed to study the antibody response against SARSCoV-2. Antibodies neutralizing SARS-CoV-2 have been extensively studied in the context of infections, vaccinations, and breakthrough infections. Antibodies, however, are pleiotropic proteins that have many functions in addition to neutralization. These include Fc-effector functions such as antibody- dependent cellular cytotoxicity (ADCC) and antibody-dependent cellular phagocytosis (ADCP). Although important to combat viral infections, these Fc-effector functions were less studied in the context of SARS-CoV-2 compared with binding and neutralization. This is partly due to the difficulty in developing reliable assays to measure Fc-effector functions compared to antibody binding and neutralization. Multiple assays have now been developed and can be used to measure different Fc-effector functions. Here, we review these assays and what is known regarding anti-SARS-CoV-2 Fc-effector functions. Overall, this review summarizes and updates our current state of knowledge regarding anti-SARS-CoV-2 Fc-effector functions.

引用

页码：756 / 768

页数：13

共 124 条

[11] A Fc-enhanced NTD-binding non-neutralizing antibody delays virus spread and synergizes with a nAb to protect mice from lethal SARS-CoV-2 infection [J].

Beaudoin-Bussieres, Guillaume ;

Chen, Yaozong ;

Ullah, Irfan ;

Prevost, Jeremie ;

Tolbert, William D. ;

Symmes, Kelly ;

Ding, Shilei ;

Benlarbi, Mehdi ;

Gong, Shang Yu ;

Tauzin, Alexandra ;

Gasser, Romain ;

Chatterjee, Debashree ;

Vezina, Dani ;

Goyette, Guillaume ;

Richard, Jonathan ;

Zhou, Fei ;

Stamatatos, Leonidas ;

McGuire, Andrew T. ;

Charest, Hughes ;

Roger, Michel ;

Pozharski, Edwin ;

Kumar, Priti ;

Mothes, Walther ;

Uchil, Pradeep D. ;

Pazgier, Marzena ;

Finzi, Andres .

CELL REPORTS, 2022, 38 (07)

[12] A new flow cytometry assay to measure antibody- dependent cellular cytotoxicity against SARS-CoV-2 Spike-expressing cells [J].

Beaudoin-Bussieres, Guillaume ;

Richard, Jonathan ;

Prevost, Jeremie ;

Goyette, Guillaume ;

Finzi, Andres .

STAR PROTOCOLS, 2021, 2 (04)

[13] Decline of Humoral Responses against SARS-CoV-2 Spike in Convalescent Individuals [J].

Beaudoin-Bussieres, Guillaume ;

Laumaea, Annemarie ;

Anand, Sai Priya ;

Prevost, Jeremie ;

Gasser, Romain ;

Goyette, Guillaume ;

Medjahed, Halima ;

Perreault, Josee ;

Tremblay, Tony ;

Lewin, Antoine ;

Gokool, Laurie ;

Morrisseau, Chantal ;

Begin, Philippe ;

Tremblay, Cecile ;

Martel-Laferriere, Valerie ;

Kaufmann, Daniel E. ;

Richard, Jonathan ;

Bazin, Renee ;

Finzi, Andres .

MBIO, 2020, 11 (05) :1-7

[14] Convalescent plasma for hospitalized patients with COVID-19: an open-label, randomized controlled trial [J].

Begin, Philippe ;

Callum, Jeannie ;

Jamula, Erin ;

Cook, Richard ;

Heddle, Nancy M. ;

Tinmouth, Alan ;

Zeller, Michelle P. ;

Beaudoin-Bussieres, Guillaume ;

Amorim, Luiz ;

Bazin, Renee ;

Loftsgard, Kent Cadogan ;

Carl, Richard ;

Chasse, Michael ;

Cushing, Melissa M. ;

Daneman, Nick ;

Devine, Dana, V ;

Dumaresq, Jeannot ;

Fergusson, Dean A. ;

Gabe, Caroline ;

Glesby, Marshall J. ;

Li, Na ;

Liu, Yang ;

McGeer, Allison ;

Robitaille, Nancy ;

Sachais, Bruce S. ;

Scales, Damon C. ;

Schwartz, Lisa ;

Shehata, Nadine ;

Turgeon, Alexis F. ;

Wood, Heidi ;

Zarychanski, Ryan ;

Finzi, Andres ;

Arnold, Donald M. .

NATURE MEDICINE, 2021, 27 (11) :2012-+

[15] Broadly Neutralizing Anti-HIV-1 Antibodies Require Fc Effector Functions for In Vivo Activity [J].

Bournazos, Stylianos ;

Klein, Florian ;

Pietzsch, John ;

Seaman, Michael S. ;

Nussenzweig, Michel C. ;

Ravetch, Jeffrey V. .

CELL, 2014, 158 (06) :1243-1253

[16] Two-component spike nanoparticle vaccine protects macaques from SARS-CoV-2 infection [J].

Brouwer, Philip J. M. ;

Brinkkemper, Mitch ;

Maisonnasse, Pauline ;

Dereuddre-Bosquet, Nathalie ;

Grobben, Marloes ;

Claireaux, Mathieu ;

de Gast, Marlon ;

Marlin, Romain ;

Chesnais, Virginie ;

Diry, Segolene ;

Allen, Joel D. ;

Watanabe, Yasunori ;

Giezen, Julia M. ;

Kerster, Gius ;

Turner, Hannah L. ;

van der Straten, Karlijn ;

van der Linden, Cynthia A. ;

Aldon, Yoann ;

Naninck, Thibaut ;

Bontjer, Ilja ;

Burger, Judith A. ;

Poniman, Meliawati ;

Mykytyn, Anna Z. ;

Okba, Nisreen M. A. ;

Schermer, Edith E. ;

van Breemen, Marielle J. ;

Ravichandran, Rashmi ;

Caniels, Tom G. ;

van Schooten, Jelle ;

Kahlaoui, Nidhal ;

Contreras, Vanessa ;

Lemaitre, Julien ;

Chapon, Catherine ;

Fang, Raphael Ho Tsong ;

Villaudy, Julien ;

Sliepen, Kwinten ;

van der Velden, Yme U. ;

Haagmans, Bart L. ;

de Bree, Godelieve J. ;

Ginoux, Eric ;

Ward, Andrew B. ;

Crispin, Max ;

King, Neil P. ;

van der Werf, Sylvie ;

van Gils, Marit J. ;

Le Grand, Roger ;

Sanders, Rogier W. .

CELL, 2021, 184 (05) :1188-+

[17] Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability [J].

Brouwer, Philip J. M. ;

Caniels, Tom G. ;

van der Straten, Karlijn ;

Snitselaar, Jonne L. ;

Aldon, Yoann ;

Bangaru, Sandhya ;

Torres, Jonathan L. ;

Okba, Nisreen M. A. ;

Claireaux, Mathieu ;

Kerster, Gius ;

Bentlage, Arthur E. H. ;

van Haaren, Marlies M. ;

Guerra, Denise ;

Burger, Judith A. ;

Schermer, Edith E. ;

Verheul, Kirsten D. ;

van der Velde, Niels ;

van der Kooi, Alex ;

van Schooten, Jelle ;

van Breemen, Marielle J. ;

Bijl, Tom P. L. ;

Sliepen, Kwinten ;

Aartse, Aafke ;

Derking, Ronald ;

Bontjer, Ilja ;

Kootstra, Neeltje A. ;

Wiersinga, W. Joost ;

Vidarsson, Gestur ;

Haagmans, Bart L. ;

Ward, Andrew B. ;

de Bree, Godelieve J. ;

Sanders, Rogier W. ;

van Gils, Marit J. .

SCIENCE, 2020, 369 (6504) :643-+

[18] Integrated immunovirological profiling validates plasma SARS-CoV-2 RNA as an early predictor of COVID-19 mortality [J].

Brunet-Ratnasingham, Elsa ;

Anand, Sai Priya ;

Gantner, Pierre ;

Dyachenko, Alina ;

Moquin-Beaudry, Gael ;

Brassard, Nathalie ;

Beaudoin-Bussieres, Guillaume ;

Pagliuzza, Amelie ;

Gasser, Romain ;

Benlarbi, Mehdi ;

Point, Floriane ;

Prevost, Jeremie ;

Laumaea, Annemarie ;

Niessl, Julia ;

Nayrac, Manon ;

Sannier, Geremy ;

Orban, Catherine ;

Messier-Peet, Marc ;

Butler-Laporte, Guillaume ;

Morrison, David R. ;

Zhou, Sirui ;

Nakanishi, Tomoko ;

Boutin, Marianne ;

Descoteaux-Dinelle, Jade ;

Gendron-Lepage, Gabrielle ;

Goyette, Guillaume ;

Bourassa, Catherine ;

Medjahed, Halima ;

Laurent, Laetitia ;

Rebillard, Rose-Marie ;

Richard, Jonathan ;

Dube, Mathieu ;

Fromentin, Remi ;

Arbour, Nathalie ;

Prat, Alexandre ;

Larochelle, Catherine ;

Durand, Madeleine ;

Richards, J. Brent ;

Chasse, Michael ;

Tetreault, Martine ;

Chomont, Nicolas ;

Finzi, Andres ;

Kaufmann, Daniel E. .

SCIENCE ADVANCES, 2021, 7 (48)

[19] Distinct Features and Functions of Systemic and Mucosal Humoral Immunity Among SARS-CoV-2 Convalescent Individuals [J].

Butler, Savannah E. ;

Crowley, Andrew R. ;

Natarajan, Harini ;

Xu, Shiwei ;

Weiner, Joshua A. ;

Bobak, Carly A. ;

Mattox, Daniel E. ;

Lee, Jiwon ;

Wieland-Alter, Wendy ;

Connor, Ruth, I ;

Wright, Peter F. ;

Ackerman, Margaret E. .

FRONTIERS IN IMMUNOLOGY, 2021, 11

[20]

Cathcart A.L., 2022, bioRxiv

← 1 2 3 4 5 6 7 8 9 10 →